Önemli: Bu içerik kişisel tıbbi değerlendirme ve muayenenin yerine geçmez. Acil durumlarda önce doktor veya acil servise başvurun — 112.
Diseases & Conditions
Hepatocellular Carcinoma (HCC)
Learn what hepatocellular carcinoma is, who is at risk, common symptoms, how diagnosis and staging are done, and why surveillance matters.
Hepatocellular carcinoma is the most common primary cancer of the liver. It often develops in people with chronic liver disease, especially cirrhosis, although not every patient follows the same path. Because early disease may produce few symptoms, regular surveillance in at-risk individuals is a major part of care. [1][2][3]
What is hepatocellular carcinoma?
HCC is a cancer that begins in liver cells rather than spreading there from another organ. This distinction matters because metastatic cancer in the liver and primary liver cancer are not the same disease. HCC is strongly linked with chronic liver injury, including hepatitis B, hepatitis C, cirrhosis from multiple causes, and certain metabolic liver diseases. [1][2][3]
Risk factors and causes
Major risk factors include cirrhosis, chronic hepatitis B, chronic hepatitis C, some inherited liver diseases, and certain metabolic or fatty liver-related conditions. The presence of chronic liver damage does not guarantee cancer, but it raises risk enough that surveillance becomes important in many patients. [1][2]
What are the symptoms?
Early HCC may cause no symptoms at all. When symptoms do appear, they can include weight loss, fatigue, abdominal discomfort, fullness, worsening liver disease signs, jaundice, or fluid buildup in the abdomen. Because these complaints can overlap with cirrhosis itself, regular follow-up matters even before obvious symptoms arise. [1][2][4]
How are diagnosis and staging done?
Diagnosis may involve imaging, liver-focused blood tests, and sometimes biopsy, depending on the clinical setting. In people with cirrhosis, certain imaging patterns can be highly informative. Staging looks beyond the tumor alone and also considers liver function and overall condition, which is especially important in liver cancer. [1][2][4]
Treatment options
Treatment depends on tumor burden, liver function, overall health, and whether curative or disease-controlling approaches are feasible. Options may include surgery, transplant pathways in selected cases, local treatments, or systemic therapy. No single treatment fits every patient because liver reserve and cancer stage both matter. [1][2][4]
Follow-up and when to seek medical care
People with cirrhosis or chronic liver disease should follow recommended surveillance plans because early detection can open more options. New jaundice, worsening abdominal swelling, unexplained weight loss, increasing weakness, or new pain should prompt medical review. [1][2][3]
Why is surveillance especially important in HCC?
HCC may be more treatable when found earlier, and at-risk patients can remain asymptomatic for some time. Surveillance is therefore not an optional extra for many people with chronic liver disease; it is a core part of risk management. [1][2]
FAQ
Is hepatocellular carcinoma the same as liver metastasis?
No. HCC starts in liver cells, whereas metastasis means a cancer from another organ has spread to the liver. [1][2]
Who gets HCC more often?
People with cirrhosis, chronic hepatitis B, chronic hepatitis C, and certain chronic liver diseases are at higher risk. [1][2][3]
Does HCC cause symptoms early?
Not always. Early disease may be silent. [1][2]
Can HCC be treated?
Yes, but options depend on stage, liver function, and overall suitability for different therapies. [1][2][4]
Why is regular monitoring important?
Because early detection may improve available treatment options and outcomes. [1][2]